Prawo i regulacje · 17/06/2019

DEA Places Solriamfetol in Schedule IV of Controlled Substances Act

The U.S. Drug Enforcement Administration has issued an interim final rule placing solriamfetol, a new drug product, in schedule IV of the Controlled Substances Act, following a recommendation from the Department of Health and Human Services.